Treatment options for ovarian cancer.
Baker
V V
VV
Wayne State University School of Medicine, Karmanos Cancer Institute, 3990 John R, 2 Webber North, Suite 2217, Detroit, MI 48201, USA.
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018394:CA-125 Antigen / Q000097:blood; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery*; D017239:Paclitaxel / Q000008:administration & dosage
D000972:Antineoplastic Agents, Phytogenic; D018394:CA-125 Antigen; D017239:Paclitaxel; D002945:Cisplatin